04/08/2024
3:38 PM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
6:07 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
6:21 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
6:01 AM | Milestone Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
8:00 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
3:52 PM | Milestone Pharmaceuticals (Filer)
| Form 424B5 | |
02/26/2024
6:06 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/14/2024
7:56 PM | Milestone Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
6:10 AM | Milestone Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/09/2024
6:41 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Milestone Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/29/2024
3:42 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Milestone Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/24/2024
1:27 PM | BlackRock Inc. (Filed by)
Milestone Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/26/2023
6:15 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:05 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
5:37 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
5:09 AM | Milestone Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
3:43 PM | Alta Fundamental Advisers LLC (Filed by)
Milestone Pharmaceuticals (Subject)
| Form SC 13D | |
11/07/2023
8:07 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:28 AM | Milestone Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
6:40 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2023
4:11 PM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
4:19 PM | Milestone Pharmaceuticals (Filer)
| Form 424B5 | |
05/29/2023
11:15 PM | Milestone Pharmaceuticals (Filer)
| Form EFFECT | |
05/11/2023
6:25 AM | Milestone Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
6:09 AM | Milestone Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2023
4:10 PM | Milestone Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
